[go: up one dir, main page]

ID23784A - Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini. - Google Patents

Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.

Info

Publication number
ID23784A
ID23784A IDW20000067A ID20000067A ID23784A ID 23784 A ID23784 A ID 23784A ID W20000067 A IDW20000067 A ID W20000067A ID 20000067 A ID20000067 A ID 20000067A ID 23784 A ID23784 A ID 23784A
Authority
ID
Indonesia
Prior art keywords
alkoxsifuramamina
compounds
making
compound obtained
compound
Prior art date
Application number
IDW20000067A
Other languages
English (en)
Inventor
Raphael Bouchet
Francis Brion
Colette Colladant
Jacques Lagouardat
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ID23784A publication Critical patent/ID23784A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW20000067A 1997-07-15 1998-07-09 Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini. ID23784A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708932A FR2766188B1 (fr) 1997-07-15 1997-07-15 Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes

Publications (1)

Publication Number Publication Date
ID23784A true ID23784A (id) 2000-05-11

Family

ID=9509210

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000067A ID23784A (id) 1997-07-15 1998-07-09 Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.

Country Status (34)

Country Link
US (1) US6235899B1 (id)
EP (1) EP0998470B1 (id)
JP (1) JP4450987B2 (id)
KR (1) KR100519691B1 (id)
CN (1) CN100363355C (id)
AP (1) AP1071A (id)
AR (1) AR015924A1 (id)
AT (1) ATE239713T1 (id)
AU (1) AU744272B2 (id)
BG (1) BG64050B1 (id)
BR (1) BR9810896A (id)
CA (1) CA2296742C (id)
CZ (1) CZ295312B6 (id)
DE (1) DE69814395T2 (id)
DK (1) DK0998470T3 (id)
EA (1) EA002883B1 (id)
EE (1) EE03873B1 (id)
ES (1) ES2197489T3 (id)
FR (1) FR2766188B1 (id)
HR (1) HRP20000027B1 (id)
HU (1) HU230148B1 (id)
ID (1) ID23784A (id)
IL (1) IL134031A (id)
ME (1) ME01708B (id)
NO (1) NO324508B1 (id)
NZ (1) NZ502338A (id)
PL (1) PL200820B1 (id)
PT (1) PT998470E (id)
RS (1) RS49832B (id)
SK (1) SK284168B6 (id)
TR (1) TR200000117T2 (id)
UA (1) UA66364C2 (id)
WO (1) WO1999003852A1 (id)
ZA (1) ZA986203B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053056B2 (en) * 1998-07-02 2006-05-30 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
EP1278737B1 (en) * 2000-04-24 2010-06-30 Vertex Pharmaceuticals Incorporated Process and intermediates for making substituted aspartic acid acetals
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
JP2003327568A (ja) * 2000-09-20 2003-11-19 Kanegafuchi Chem Ind Co Ltd 光学活性β−アミノ酸誘導体の製造方法
JPWO2002055478A1 (ja) * 2001-01-16 2004-05-13 鐘淵化学工業株式会社 光学活性アミノラクトン誘導体の製造法およびその中間体
JP2007525503A (ja) 2004-02-27 2007-09-06 バーテックス　ファーマシューティカルズ　インコーポレイテッド カスパーゼインヒビターおよびそれらの使用
DK2399916T3 (en) 2004-03-12 2015-03-02 Vertex Pharma A process and intermediates for the preparation of asparaginacetal-caspase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
PT998470E (pt) 2003-09-30
BG64050B1 (bg) 2003-11-28
ATE239713T1 (de) 2003-05-15
DE69814395D1 (de) 2003-06-12
AU8633398A (en) 1999-02-10
UA66364C2 (uk) 2004-05-17
CZ200065A3 (cs) 2000-07-12
JP4450987B2 (ja) 2010-04-14
AP2000001732A0 (en) 2000-03-31
NO20000182L (no) 2000-03-07
CN100363355C (zh) 2008-01-23
EA002883B1 (ru) 2002-10-31
EP0998470A1 (fr) 2000-05-10
IL134031A (en) 2004-06-01
BG104073A (en) 2001-05-31
EE03873B1 (et) 2002-10-15
KR100519691B1 (ko) 2005-10-13
YU1500A (sh) 2002-10-18
DE69814395T2 (de) 2003-12-11
ZA986203B (en) 1999-08-18
EA200000127A1 (ru) 2000-08-28
AR015924A1 (es) 2001-05-30
NZ502338A (en) 2001-09-28
HUP0003857A2 (hu) 2001-04-28
HRP20000027B1 (en) 2006-07-31
DK0998470T3 (da) 2003-09-01
FR2766188B1 (fr) 2000-02-11
TR200000117T2 (tr) 2000-07-21
EE200000024A (et) 2000-10-16
JP2001510191A (ja) 2001-07-31
CN1269795A (zh) 2000-10-11
HUP0003857A3 (en) 2002-08-28
AU744272B2 (en) 2002-02-21
US6235899B1 (en) 2001-05-22
PL338035A1 (en) 2000-09-25
ES2197489T3 (es) 2004-01-01
SK302000A3 (en) 2000-11-07
BR9810896A (pt) 2000-09-26
HU230148B1 (hu) 2015-09-28
CA2296742C (fr) 2009-12-08
CA2296742A1 (fr) 1999-01-28
FR2766188A1 (fr) 1999-01-22
WO1999003852A1 (fr) 1999-01-28
SK284168B6 (sk) 2004-10-05
CZ295312B6 (cs) 2005-07-13
KR20010021834A (ko) 2001-03-15
EP0998470B1 (fr) 2003-05-07
AP1071A (en) 2002-05-20
IL134031A0 (en) 2001-04-30
NO20000182D0 (no) 2000-01-14
NO324508B1 (no) 2007-11-05
ME01708B (me) 2008-08-07
RS49832B (sr) 2008-08-07
HRP20000027A2 (en) 2000-10-31
PL200820B1 (pl) 2009-02-27

Similar Documents

Publication Publication Date Title
ID18046A (id) Senyawa siklik campuran, pembuatan dan penngunaannya.
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ZA9810125B (en) Chemical compounds.
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
NO20003139D0 (no) FremgangsmÕte for syntese av 1,3-dioler
ID30299A (id) Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
ID20547A (id) Hasil adisi magnesium diklorida-alkohol, proses untuk penyediaannya dan komponen katalis yang dihasilkannya
ZA971645B (en) Chemical compounds.
ZA9710314B (en) Chemical compounds.
ZA975953B (en) Chemical compounds.
ZA975436B (en) Chemical Compounds.
ID29236A (id) Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya
ID16128A (id) Turunan arilglisinamida baru, proses pembuatannya dan komposisi-komposisi farmasi yang mengandung senyawa ini
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
ZA966427B (en) The preparation of fluorinated organic compounds.
ID23436A (id) Senyawa-senyawa akrilonitril, proses untuk produksinya dan pestisida-pestisida yang mengandungnya
TR199901877A3 (tr) Zararli eklem bacaklilarin imhasi için terkip.
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID29295A (id) Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut
DE69905451D1 (de) Neue triazolo(4,5d) pyrimidinverbindungen
ZA991841B (en) Chemical Compounds.
ZA98755B (en) Substituted hydroxy-anilino derivatives of cyclobutane-3,4-diones.
ID23784A (id) Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.
ZA9810063B (en) Process for the manufacture of an organic compound.
ZA991032B (en) Chemical compounds.